Innoviva, Inc.
INVA
$22.41
$0.090.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 49.47% | 34.51% | 45.53% | 80.82% | 63.34% |
| Total Other Revenue | -2.17% | -0.52% | -0.26% | 0.30% | 1.21% |
| Total Revenue | 14.67% | 10.14% | 12.02% | 18.70% | 15.54% |
| Cost of Revenue | 172.86% | 2.64% | -34.41% | -50.48% | -64.96% |
| Gross Profit | -1.56% | 11.75% | 22.52% | 41.18% | 51.16% |
| SG&A Expenses | -2.05% | 1.77% | -1.39% | 3.63% | 17.85% |
| Depreciation & Amortization | 1.45% | 0.97% | 0.55% | 6.22% | 18.90% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.96% | 23.05% | 5.68% | -1.81% | -3.77% |
| Operating Income | -5.08% | -2.54% | 19.59% | 49.45% | 45.42% |
| Income Before Tax | 774.24% | 111.81% | -57.15% | -123.39% | -80.74% |
| Income Tax Expenses | 297.95% | 213.59% | 255.20% | -19.73% | -2.64% |
| Earnings from Continuing Operations | 1,059.22% | 97.15% | -73.42% | -132.93% | -86.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1,059.22% | 97.15% | -73.42% | -132.93% | -86.98% |
| EBIT | -5.08% | -2.54% | 19.59% | 49.45% | 45.42% |
| EBITDA | -4.25% | -2.10% | 16.78% | 42.32% | 41.40% |
| EPS Basic | 924.70% | 88.04% | -72.73% | -133.73% | -86.70% |
| Normalized Basic EPS | -7.00% | 1.19% | 27.32% | 60.36% | 56.83% |
| EPS Diluted | 1,378.89% | 102.19% | -80.10% | -144.82% | -90.54% |
| Normalized Diluted EPS | -10.33% | -6.82% | 30.64% | 86.28% | 71.95% |
| Average Basic Shares Outstanding | 7.38% | 2.09% | -1.42% | -2.63% | -4.16% |
| Average Diluted Shares Outstanding | 7.88% | 7.23% | -7.51% | -15.19% | -9.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |